Medical Marijuana Inc (MJNA)

[NavyMSU]

Given the stock structure, lets round it up to a 1B S/O because why would they stop diluting in Q1 with negative cash flows?

Say they sell $15M in actual product revenues, 5 * revenues is a valuation of $75M, that translates to 7.5¢ per share.

This company won't see high trading ratios until they're proven sustainable and are on the NYSE and the movement towards rescheduling has serious momentum (which it currently does not).

So even I don't think .05 will happen, but .075 is very likely. However I don't expect growth above .10 for a year (I expect them to continue to dilute because they obviously have poor cash management skills).

It would be nice if they could expedite the mythical audit (I know, I know, "no sooner than end of Q2", which could be next year) and get that uplist before .10 is broken.

Get the uplist before .10 and they can reverse split to reinforce the price to reduce the risk of falling below .10 and being on warning for involuntarily down-listing by OTC.

They just need a 3:1 reverse split... Nothing dramatic.